DJIA 15,354.40 121.18 0.80%
NASDAQ 3,498.97 33.73 0.97%
S&P 500 1,667.47 17.00 1.03%

Valeant Pharmaceuticals Intern...

NYSE: VRX

+ Add to Portfolio

company name or ticker

Merz Drops Out of Bidding for Obagi Medical

Valeant wins.
4/8/2013 by DailyFinance

Valeant Inks Deal with Actavis - Analyst Blog

Valeant Inks Deal with Actavis - Analyst Blog
4/8/2013 by Zacks

Isis: Big Pharma's Little Friend

This Huntington's disease partnership could revolutionize treatments -- or fail out in trials. What does this new deal mean for Isis?
4/8/2013 by DailyFinance

U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH

4/8/2013 by Smart Money

Merz Pharma Withdraws Offer for Obagi Medical After Valeant's Sweetened Bid

4/8/2013 by Smart Money

3 Humongous Health-Care Stocks This Week

These health care stocks made big gains to open the new month.
4/6/2013 by DailyFinance

Setback for Valeant Pharma - Analyst Blog

4/5/2013 by Zacks

Valeant Ups Offer for Obagi - Analyst Blog

Valeant Ups Offer for Obagi - Analyst Blog
4/4/2013 by Zacks

Another Generic Launch at Mylan - Analyst Blog

4/4/2013 by Zacks

Valeant to Launch Own Version of Generic Zovirax in Response to Mylan's

4/4/2013 by Smart Money
See More Articles...